Location History:
- Västra Frölunda, SE (2014 - 2016)
- Gallstad, SE (2013 - 2019)
- Gällstad, SE (2006 - 2020)
Company Filing History:
3 out of 4 
3 out of 3 
2 out of 2 Years Active: 2006-2020
Title: Thomas Hedner: Innovator in Pharmaceutical Science
Introduction
Thomas Hedner, an accomplished inventor based in Gällstad, Sweden, holds an impressive portfolio of 11 patents. His work primarily focuses on advancements in pharmaceuticals, particularly in glucocorticoid replacement therapy and antimicrobial compositions, making significant contributions to medical science.
Latest Patents
Among Hedner's latest innovations is a patent on pharmaceutical compositions for glucocorticoid replacement therapy. This invention provides formulations designed to deliver glucocorticoids effectively, mimicking the serum levels of a healthy individual. The technology enables a two-part release mechanism, wherein a portion of the glucocorticoids is released immediately, while another part is delivered gradually over a period of at least 8 hours. This innovation is particularly beneficial for treating conditions associated with glucocorticoid deficiency disorders.
Additionally, Hedner has developed an antimicrobial and anti-inflammatory composition involving the use of davanone and 1,8-cineol. This patent outlines the methodology for producing a composition that can effectively target microbial and inflammatory conditions, showcasing his dedication to improving patient care through innovative pharmaceutical solutions.
Career Highlights
Throughout his career, Thomas Hedner has worked with prominent companies in the pharmaceutical industry, including Laccure AB and Ambria Dermatology AB. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and contribute to various research initiatives.
Collaborations
Hedner has collaborated with distinguished colleagues, including Olov Sterner and Jan Faergemann. These partnerships have fostered an environment of innovation, leading to breakthroughs in pharmaceutical research and the development of new therapeutic solutions.
Conclusion
Thomas Hedner's contributions to the field of pharmaceuticals, particularly through his patented inventions, highlight his position as a leading innovator. With a robust background and collaborative spirit, he continues to make a significant impact on medical science, aiming to enhance the quality of life for patients requiring glucocorticoid treatments and antimicrobial therapies. His work exemplifies the importance of innovation in addressing critical health challenges.